2.1 Local Anaesthetics Flashcards

1
Q

Local anaesthetics (LAs) work by
used
`

A

Reversible Na+ channel blockers

used clinically to produce neuraxial anaesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What was the first LA
used by who

Who isolated this

What was its first clinical use

What was the first synthetic LA
invented when

A

The use of leaves of coca plant
(Erythroxylon coca) for topical anaesthesia
was known to Incas.

In 1859, Albert Niemann isolated the
chief alkaloid of coca,
which he named ‘cocaine’.

In 1884, Carl Koller became the first
to use cocaine for ophthalmic anaesthesia.

The first synthetic LA was benzocaine (1900).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the structure

How are they classified

A

LA molecule consists of a

  • hydrophobic aromatic ring
  • hydrophilic tertiary amine group

held by a hydrocarbon chain
(with an ester or amide linkage),

hence classified as esters or amides.

https://www.bjaed.org/article/S2058-5349(19)30152-0/fulltext

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Are LA acids or bases

A

Because the tertiary amine group

can bind a proton to become a
positively charged quaternary amine,

all LAs exist as a
weak acid– base pair in solution.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does their structure affect its mechanism

A

This is most vital for LA action,
as it is the cationic species that binds
to the Na+ channel from inside the cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which LA is different in structure

A

An exception to this is benzocaine, which lacks the tertiary amine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name some other

chemicals / drugs / substances

that inhibit Na channels

A

Many chemicals inhibit Na+ channels including

adrenergic agonists
tricyclic antidepressants
general anaesthetics
substance P inhibitors
menthol
and nerve toxins 
(saxitoxin, scorpion toxin and tetrodotoxin).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do the nerve toxins differ from LA

A

The nerve toxins block the Na+ channel from the extracellular side

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Properties of Esters

Bond
Metabolism
Potency
Synthesis
Allergic reaction
Duration
Toxicity
Examples
A

Bond
Ester

Metabolism
Plasm esterases

Potency
Generally less ( - tetracaine)

Synthesis
Manufactured first

Allergic reaction
Commoner cause of PABA
(para aminobenzoic acid)

Duration
Shorter

Toxicity
Generally less ( - tetracaine / cocaine)
Examples
Benzocaine
Procaine
Tetracaine
2-Chlorprocaine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Properties of Amides

Bond
Metabolism
Potency
Synthesis
Allergic reaction
Duration
Toxicity
Examples
A

Bond:
Amide

Metabolism
Hepatic enzyme N-Dealkylation + Hydroxylation

Potency
More

Synthesis
Later

Allergic reaction
Rare

Duration
Longer

Toxicity
More

Examples
Lignocaine
Mepivacaine
Prilocaine
Bupivacaine
Ropivacaine
Levobupivacaine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a steroIsomer

A
Stereoisomerism describes those compounds 
which have the same 
molecular formula 
and 
chemical structure, 

but a different three dimensional configuration.

Stereoisomers may be geometric or optical (enantiomers).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Geometric isomerism

A

Geometric isomerism
(or cis–trans isomerism)

describes the orientation of functional groups
within the molecule.

Such isomers typically contain double bonds
or ring structures,
where the rotation of bonds is greatly restricted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Optical isomers have

A

Optical isomers have chiral centres,
eg - quaternary nitrogen
- carbon atom surrounded by diff chemical groups.

Chiral molecule,
- lacks an internal plane of symmetry.

These molecules have
non-superimposable mirror images,
imparting a particular type of stereoisomerism
called enantiomerism.

Non-superimposable mirror images
depending on the configuration exist
as R (rectus) and S (sinistra) isomers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chiral examples

A
Many substances in anaesthesia are chiral 
volatile anaesthetics, 
ketamine,
thiopental 
local anaesthetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Achiral examples 4

A

few anaesthetic substance are Achiral

sevoflurane,
lignocaine,
procaine,
tetracaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Optical rotation

What are the types

A

Optical rotation (optical activity)

ability to turn the plane of linearly polarised light
about the direction of motion as the light
travels through a substance.

Pure enantiomers may 
be dextrorotatory (d), (+) 
or levorotatory (l), (–).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How can isomers be classified based on properties

A

Based on the above two properties isomers

can be referred to as

R(+) and R(–) or S(+) and S(–) isomers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Non-superimposable mirror images

depending on the configuration exist

A

Non-superimposable mirror images
depending on the configuration exist
as R (rectus) and S (sinistra) isomers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Racemic mixtures consist of

How do they effect light

A

Racemic mixtures consist of

equal amount of both enantiomers,

and

therefore do not rotate polarised light
in either direction.

Pure enantiomers may have differences
in absorption, distribution, potency, therapeutic
action and most importantly toxicity profiles (ropivacaine and levobupivacaine).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Non-racemic mixtures have

A

Non-racemic mixtures have
unequal amounts
of two enantiomers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pure enantiomers may have differences in

A

Pure enantiomers may have differences in

absorption,
distribution,
potency,
therapeutic action and

most importantly toxicity profiles
(ropivacaine and levobupivacaine).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

The important physicochemical properties of LA x5

A

molecular weight (MW),

pKa (ionisation),

aqueous solubility,

lipid solubility

protein binding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

MW:

A

MW:

Addition of a butyl group to mepivacaine (MW 246) results in
formation of bupivacaine (MW 288).

This increase in molecular weight
results in

higher lipid solubility, i.e. partition coefficient (pKa), higher protein binding and higher potency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

pKa is

A

pKa:

is the pH at which half the LA molecules are in the base form and half in the acid form.

Most LAs have a pKa between 7.5 and 9.0
(weak bases).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How are LA supplied

what happens when they are injected into tissue

A
Because the LAs are supplied
as unbuffered acidic solutions
(salts of HCl) 
with  pH of 3.5–5.0, 
the ionised form predominate. 

On injection into tissues (pH 7.4),
the unionised form predominates and
enters the cell to produce Na+ blockade.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How does pKa affect speed of onset

A

The closer the pKa to the extracellular pH (7.4),

the higher the number of
unionised forms available
and the faster the onset of action.

Hence lignocaine with (pKa 7.7)
has faster onset
than bupivacaine (pKa 8.1).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Aqueous solubility

relies on

related to

A

Aqueous solubility:
It is the presence of the

tertiary amine group

that provides for ionisation
and hence aqueous solubility.

It is related directly to the extent of
ionisation and inversely to its lipid solubility.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What property of Benzocaine differentiates it

A

Benzocaine lacks an
ionisable amino group,
and
therefore has poor aqueous solubility,

restricting it to only topical use.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Lipid solubility

depends on

proportional to

A

Lipid solubility:
(sometimes wrongly called hydrophobicity)

dependent on the size of the

alkyl group on tertiary amine increasing with its size.

It is directly proportional to

  • LA potency,
  • duration of action
  • and toxicity.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

The distribution coefficient of LA is

A

The distribution coefficient of LA is

the ratio of concentration of LA 
in a mix of 
an aqueous buffer
and a hydrophobic lipid (octanol) 
after separation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

The partition coefficient

A

The partition coefficient is the
distribution coefficient at pH of 7.4
(octanol : buffer 7.4).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Protein binding

proportional to

binds to which proteins

decreases with

A

In general,

lipophilicity is proportional to protein binding.

LA binds to both 
α1-acid glycoprotein 
\+
albumin,
and this is pH-dependent, 

decreasing with acidosis
increasing the amount of
free drug in acidic environment.

This lowers safety of LA in hypoproteinemic
conditions:

malnutrition,
nephrotic syndrome
cirrhosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

6 Common features of local anaesthetics

A

Common features of local anaesthetics
Property Implication

1
Weak bases with pKa > 7.4
Free base has poor aqueous solubility

2
Available as acidic solutions (HCl salts)
Results in improved aqueous solubility

3
Exist in equilibrium of free base (unionised, lipid-soluble) and cationic (ionised, water-soluble)
This equilibrium can be shifted to either side by altering the pH of solution (hence adding HCO3 to LA increases the availability of free base)

4
Body buffers raise pH
This raises the amount of free base present; the closer the pKa to the extracellular pH (7.4), the faster the onset of action

5
Free base (lipid-soluble) crosses neural memranes Passes intracellularly to be ionised
6
Cationic moiety (water-soluble) is the active part
It blocks the Na+ channel from the inside
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Weak bases with pKa > 7.4

A

1
Weak bases with pKa > 7.4

=

Free base has poor aqueous solubility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Available as acidic solutions (HCl salts)

A

2
Available as acidic solutions (HCl salts)

=

Results in improved aqueous solubility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Exist in equilibrium of free base

and cationic

A

3
Exist in equilibrium of free base
(unionised, lipid-soluble) and

cationic (ionised, water-soluble)

=

This equilibrium can be shifted
to either side by
altering the pH of solution

(hence adding HCO3 to LA increases
the availability of free base

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Body buffers raise pH

A

4
Body buffers raise pH

=

This raises the amount of free base present;
the closer the pKa to the extracellular pH (7.4),
the faster the onset of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Free base (lipid-soluble) crosses neural memranes

A

Free base (lipid-soluble) crosses neural memranes

=

Passes intracellularly to be ionised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Cationic moiety (water-soluble) is the active part

A

Cationic moiety (water-soluble) is the active part

=

It blocks the Na+ channel from the inside

40
Q

2-Chlorprocaine

type

potency
onse
duration

what use

A

2-Chlorprocaine is a congener of
procaine and thus an ester.

It has low potency,
a fast onset and
short duration of action.

It has been recently used for ambulatory surgeries under spinal anaesthesia.

41
Q

Are most LAs chiral or achiral

are there exceptions 3

A

Most LAs are chiral, except lignocaine, procaine and tetracaine.

42
Q

How do Ropivacaine and Bupivacaine differ

How does this affect their properties

A

Ropivacaine has a propyl group
in its tertiary amine,

while bupivacaine has a butyl group.

This probably explains
its lower potency,
lower lipid solubility
and lower toxicity than bupivacaine.

43
Q

Are LA vasoconstrictors or dilators

is there any exceptions

A

All LAs are vasodilators
(at high concentration),

except
cocaine and ropivacaine,

which are vasoconstrictors

44
Q

basis of their anaesthetic profile, LAs are classified as

Potency & Duration

A

Low potency and short duration
(procaine and 2-chlorprocaine)

intermediate potency and duration
(prilocaine, lignocaine and mepivacaine)

high potency and long duration of action
(tetracaine, etidocaine, bupivacaine and ropivacaine).

45
Q

duration of LA action depends on

A

duration of LA action depends on the
dose and
the route of injection;

ideally, the recommended doses
should be block-specific.

46
Q

Issues with cocaine & Uuse

A

Cocaine is toxic and used topically in ophthalmic anaesthesia.

47
Q

What can cause methaemoglobinaemia

A

Benzocaine and prilocaine may cause methaemoglobinaemia.

48
Q

How do Ropiv and Bupiv differ

how does this affect them

A

Ropivacaine has a propyl group in its tertiary amine, while bupivacaine has a butyl group.
It is less soluble,
less potent
and less toxic

than bupivacaine.
It produces less motor block as well.

49
Q

who share a pipechol ring
(2’,6’-pipecoloxylidide).

4

A

Mepivacaine,
bupivacaine,
ropivacaine
and levobupivacaine

share a pipechol ring (2’,6’-pipecoloxylidide).

50
Q

What must be crossd before reaches nerve

A

Multiple neuronal barriers
(epineurium,
perineurium and
endoneurium)

must be crossed before LA can reach the nerve.

51
Q

What decreases onset

What is most important factor for speed of onset

technique

A

The vasularity of the surrounding tissue,
fascial layers
and LA absorption by fat

all have a detrimental effect
on the delivery of LA to the nerve,

and result in a decrease in onset.

Hence, the proximity of
injection to the nerve is
the most important factor determining the
onset of LA action.

52
Q

Addition of what can speed up onset

A

Importantly, it has been noted that the
addition of vasoconstrictors
and hyaluronidase

may hasten the onset times.

53
Q

Is it volume concentration or dose that affects onset time

A

LA dose rather than the
volume or concentration
has been observed to
affect the onset times.

54
Q

How does lipophilicity affect speed onset

why

whats an example of this

A

Lipophilic LAs are more
likely to partition away from
the hydrophilic extracellular fluid compartment

into surrounding tissues
and may bind to connective tissues
rather than the nerve,

and hence they have a slower onset.

Clinically, bupivacaine (higher lipid solubility)
has a slower onset than
lignocaine (less lipid-soluble).

55
Q

Block duration is largely dependent on the

A

Block duration is largely dependent on the drug clearance rate.

56
Q

How does dose affect duration

A

The larger the dose given,
and the slower the metabolism
and clearance,

the greater the duration will be

57
Q

How does lipid solubility affect duration

A

More lipid-soluble LAs have
longer duration of action
because of slower clearance.

Higher protein binding increases duration of action by virtue of
lowering the free drug available for metabolism

58
Q

How does vaso constriction / dilation affect duration

A

At higher doses,
LAs produce vasodilatation,
enhancing their own clearance.

Addition of vasoconstrictors
may reduce clearance and enhance duration.

59
Q

How does protein binding affect duration

A
Higher protein binding 
increases duration of action 
by virtue of
lowering the free drug 
available for metabolism.
60
Q

How does the addition of adrenaline affect
systemic absorption

How does this affect onset time
degree of block
duration

A
The addition of vasoconstrictors 
such as adrenaline to LA 
acts by 
decreasing systemic absorption 
of the LA.

This means more LA is
available to act locally
(on the peripheral nerve) :

decreasing onset time,
but improving the
degree of sensory
and motor block,

duration of the block
and the area (extent) covered.

61
Q

How is the toxicity of LA affected by vasoconstrictors

What group may this not work on

A

The toxicity of LA may be reduced
by lowering the peak plasma concentration,
allowing administration of a greater dose.

However, the effect of longer-acting
LAs like bupivacaine
may not be much affected.

62
Q

What produces pharmacological & clinical effects of LA

A

The pharmacological effects
(neural blockade)

and clinical effects
(analgesia and anaesthesia)

of LAs are the result of the drug
absorption and its disposition.

63
Q

What is disposition

A

Disposition refers collectively to the

process of drug distribution
(into and out of the tissues)

and drug elimination
(by metabolism and excretion).

An injection of LA undergoes
local disposition,
systemic absorption
and systemic disposition.

64
Q

Local disposition of an injection drug pool near the nerve undergoes

A

Local disposition of an injection drug pool
near the nerve undergoes:

neural tissue uptake, 
non-neural tissue uptake, 
uptake by fat, 
and
redistribution to cerebrospinal fluid (if neuraxial). 

This involves both
bulk flow and diffusion.

It is the neural tissue uptake
that results in
neural blockade (clinical effect).

65
Q

What is chiefly responsible for systemic toxicity

How is this inferred

A

Systemic absorption of LA is
chiefly responsible for its systemic toxicity
(side effect).

This is inferred from
peak plasma concentration (Cmax)
and the time of its occurrence (Tmax).

This is not absolute, as the peak plasma
concentration reflects the net result of systemic absorption and disposition.

66
Q

Systemic disposition

Lipophilicity

A

Lipophilicity

Systemic absorption of longer-acting,
more lipophilic agents is slower

Lignocaine absorption is faster,
but bupivacaine is absorbed slowly
into the circulation

67
Q

Systemic disposition

Site of administration

What is absoption by site in descending order

A

Site of administration

Anatomical features such as 
vasularity and presence of 
tissues and fat that can
bind LA 
influences disposition
Intravascular >
intrapleural > 
intercostal >
caudal > 
epidural > 
brachial plexus >
femoro-sciatic > 
subcutaneous > 
intraarticular> 
spinal
68
Q

Systemic disposition

Dosage

A

Dosage

All other factors being constant, 
dose is the primary determinant
 of peak plasma concentrations 
after any route
of injection

Cmax ∝ dose given;
therefore, increased Cmax

69
Q

Systemic disposition

Speed of injection

A

Speed of injection

Accidental intravenous administration
of LA may result
in higher peak (Cmax)
with higher speed of injection

Dose fractionation may allow early
detection of systemic toxicity

70
Q

Systemic disposition

Vasocontrictor

A

Vasocontrictor

Decrease rate of systemic absorption
by reducing uptake

Decreased Cmax

71
Q

Systemic disposition

Depot formulations

A

Depot formulations

Slow the release of local anaesthetic
and hence its absorption

Decreased Cmax

72
Q

The systemic disposition of LA involves

2 processes and their constituents

A
The systemic disposition of LA involves 
both its 
distribution 
(uptake by lung, 
plasma proteins 
and tissues) 

and its elimination
(metabolism
and excretion).

73
Q

What is the first capillary bed reached by LA when exposed to systemic circulation

How does this affect its toxicity profile

A

Lung is the first capillary bed to be exposed to LA once
it has entered the systemic circulation. This delays and reduces the
exposure of brain and heart to LA

74
Q

Is protein binding in blood saturable / non

What happens to drug fraction with increasing dose

A

Protein binding of LA in blood
is a saturable process.

This implies that as the dose increases,
the fraction of drug
bound to plasma proteins falls

(after saturation of all binding sites).

75
Q

Describe the two types of plasma binding

A

Binding is of two types:
high affinity and low capacity

(α1-acid glycoprotein)

and

low affinity and high capacity (albumin).

76
Q

What conditions affect the amount of a1-acid glycoprotein

How do these affect binding

A

In elevation of the amount of
α1-acid glycoprotein

cancer, 
inflammatory states, 
chronic pain,
trauma, 
uraemia, 
post-operatively)

binding capacity increases.

77
Q

What conditions decrease a1-acid glycoprotein

A

However, with a decline in its level
(pregnancy and neonates),

this binding may be limited,
resulting in a higher free fraction of LA

78
Q

How are Ester LAs metabolised

How is this affected in hepatic and renal disease

A

Ester LAs are rapidly cleared

by plasma pseudocholinesterase.

In hepatic and renal disease,
a decreased synthesis of
pseudocholinesterase

may be responsible for
its prolonged half-life.

The erythrocyte esterase activity is preserved.

79
Q

How are the Amides metabolised *

A
The amides are metabolised in liver 
by 
N-dealkylation 
and 
hydroxylation.
80
Q

How is Etidocaine cleared

compared to that of

Ropiv + Bupiv

How is Lignocaine cleared

A

Etidocaine clearance is dependent
mostly on liver blood flow,

whereas that of ropivacaine and bupivacaine

is dependent on
hepatic enzymatic activity.

The clearance of lignocaine is dependent
on both hepatic blood flow and enzyme activity.

81
Q

Amide LAs structurally

How are they metaboilised

A

Amide LAs structurally have an
alkyl chain,
an aromatic ring and
an amide bond between the two.

They undergo N-dealkylation, aromatic
hydroxylation and amide hydrolysis in liver.

82
Q

What enzyme metabolises Lignocaine

A

Lignocaine undergoes N-dealkylation by CYP3A4.

83
Q

How are Bupivicaine + Ropiv metabolised

what enzymes

A

Both bupivacaine and ropivacaine

undergo N-dealkylation (CYP3A4)

and hydroxylation (CYP1A2).

84
Q

What substance can affect Metab of:

Bupiv

Ropiv

A

Inhibitors of CYP3A4
(Itraconazole) reduce bupivacaine elimination

while those of CYP1A2 (Fluvoxamine)
reduced ropivacaine clearance.

85
Q

What can affect metabolise of all amides

A

Inhibitors of CYP2D6
(beta blockers and H2 antagonists)

reduce hepatic blood flow
and reduce metabolism of amide LA.

86
Q

Effects of patient variables
on disposition of amide local anaesthetics

Foetus/age
< 6 months

A

Reduced metabolism

Deficiency of CYP3A4

Use lower doses

87
Q

Effects of patient variables on disposition of amide local anaesthetics

Elderly

A

Clearance of LA decreases
with increasing age

Reduced hepatic mass
in elderly

Use lower doses

88
Q

Effects of patient variables on disposition of amide local anaesthetics

Obese

A

Terminal eliminationhalf-life of
lignocaine is prolonged

Increased volume of distribution
rather than a
decreased clearance

Dose according to
total body weight

89
Q

Effects of patient variables on disposition of amide local anaesthetics

Cardiovascular disease

A

High Cmax due to
low volume of distribution
and clearance

Reduced hepatic blood flow
and hepatocellular dysfunction

Use lower doses

90
Q

Effects of patient variables on disposition of amide local anaesthetics

Hepatic disease

A

Prolonged half-life

Reduced hepatic blood flow
and hepatocellular dysfunction

Use lower doses

91
Q

Effects of patient variables on disposition of amide local anaesthetics

Renal disease

A

Disposition kinetics are unaffected

Amides are metabolised by liver

In severe renal insufficiency,
clearance is halved and
metabolites accumulate

92
Q

How are ester LA affected by
hepatic disease,
renal disease or
pregnancy

A

ester LAs are

largely unaffected

by hepatic disease, renal disease or pregnancy

93
Q

How are Pseudocholinesterase levels affected in pregnancy

How does this effect ester LA metabolism

A

In pregnancy,
though pseudocholinesterase levels
may be decreased,

the metabolism of ester LA is
relatively preserved.

Hence they have better toxicity profiles.

94
Q

How is lignocaine metabolism affected in pregnancy

How does this occur

A

Lignocaine is more dependent on hepatic blood
flow, which is increased in pregnancy.

This increases its clearance.

95
Q

How does pregnancy affect Neural Sensitivity to LA

Why

Does this affect myocardial sensitivity to Ropiv

A

Pregnancy also increases neural sensitivity to LA.

This has been attributed to progesterone.

However, progesterone has
little effect on myocardial sensitivity
to ropivacaine,
as shown by in vitro studies

96
Q

How is Bupivacaine metabolism affected by pregnancy

A

Bupivacaine is more dependent

on hepatic enzymatic activity,
which is reduced in pregnancy,

reducing its clearance.